ES2887338T3 - Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino - Google Patents
Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino Download PDFInfo
- Publication number
- ES2887338T3 ES2887338T3 ES17799674T ES17799674T ES2887338T3 ES 2887338 T3 ES2887338 T3 ES 2887338T3 ES 17799674 T ES17799674 T ES 17799674T ES 17799674 T ES17799674 T ES 17799674T ES 2887338 T3 ES2887338 T3 ES 2887338T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- trigeminal
- pharmaceutical composition
- trigeminal neuralgia
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- GFHAXPJGXSQLPT-VIFPVBQESA-N NC(O[C@@H](C[n]1nncn1)c1ccccc1Cl)=O Chemical compound NC(O[C@@H](C[n]1nncn1)c1ccccc1Cl)=O GFHAXPJGXSQLPT-VIFPVBQESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061386 | 2016-05-19 | ||
| PCT/KR2017/005172 WO2017200317A1 (ko) | 2016-05-19 | 2017-05-18 | 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2887338T3 true ES2887338T3 (es) | 2021-12-22 |
Family
ID=60325324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17799674T Active ES2887338T3 (es) | 2016-05-19 | 2017-05-18 | Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11207295B2 (enExample) |
| EP (1) | EP3459542B1 (enExample) |
| JP (1) | JP6960415B2 (enExample) |
| KR (1) | KR102421013B1 (enExample) |
| CN (1) | CN109310669B (enExample) |
| AU (1) | AU2017267160B2 (enExample) |
| CA (1) | CA3024284C (enExample) |
| DK (1) | DK3459542T3 (enExample) |
| ES (1) | ES2887338T3 (enExample) |
| MX (1) | MX389613B (enExample) |
| PL (1) | PL3459542T3 (enExample) |
| PT (1) | PT3459542T (enExample) |
| RU (1) | RU2751504C2 (enExample) |
| WO (1) | WO2017200317A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102635936B1 (ko) | 2016-12-14 | 2024-02-13 | 에스케이바이오팜 주식회사 | 탈수초성 질환의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
| JP7408643B2 (ja) * | 2018-09-21 | 2024-01-05 | エスケー バイオファーマスティカルズ カンパニー リミテッド | カルバメート化合物及びそれを含む製剤の急性ストレス障害又は心的外傷後ストレス障害の予防、軽減又は治療のための使用 |
| WO2020080866A1 (ko) * | 2018-10-19 | 2020-04-23 | 에스케이바이오팜 주식회사 | 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) * | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| DE2628420A1 (de) * | 1976-06-24 | 1978-01-05 | Bayer Ag | 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide |
| SK57899A3 (en) * | 1996-12-31 | 2000-05-16 | Guilford Pharm Inc | N-linked ureas and carbamates of heterocyclic thioesters |
| RU2283106C2 (ru) * | 2001-02-27 | 2006-09-10 | Орто-Макнейл Фармасьютикал, Инк. | Производные карбаматов для использования для лечения боли |
| US7598279B2 (en) | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| JP4227121B2 (ja) * | 2005-06-08 | 2009-02-18 | 独立行政法人科学技術振興機構 | 神経因性疼痛治療剤 |
| CN102803233B (zh) * | 2009-06-22 | 2017-03-01 | 爱思开生物制药株式会社 | 制备氨基甲酸(r)‑1‑芳基‑2‑四唑基‑乙酯的方法 |
| US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| CA2817290A1 (en) * | 2010-11-11 | 2012-05-18 | Josef Penninger | Compounds and methods for treating pain |
| MA39448B1 (fr) * | 2014-05-09 | 2019-12-31 | Tecnimede Sociedade Tecnico Medicinal S | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical |
-
2017
- 2017-05-16 KR KR1020170060713A patent/KR102421013B1/ko active Active
- 2017-05-18 CA CA3024284A patent/CA3024284C/en active Active
- 2017-05-18 EP EP17799674.1A patent/EP3459542B1/en active Active
- 2017-05-18 JP JP2018560617A patent/JP6960415B2/ja active Active
- 2017-05-18 MX MX2018014081A patent/MX389613B/es unknown
- 2017-05-18 ES ES17799674T patent/ES2887338T3/es active Active
- 2017-05-18 WO PCT/KR2017/005172 patent/WO2017200317A1/ko not_active Ceased
- 2017-05-18 PL PL17799674T patent/PL3459542T3/pl unknown
- 2017-05-18 RU RU2018144784A patent/RU2751504C2/ru active
- 2017-05-18 US US16/302,860 patent/US11207295B2/en active Active
- 2017-05-18 PT PT177996741T patent/PT3459542T/pt unknown
- 2017-05-18 AU AU2017267160A patent/AU2017267160B2/en active Active
- 2017-05-18 CN CN201780030912.5A patent/CN109310669B/zh active Active
- 2017-05-18 DK DK17799674.1T patent/DK3459542T3/da active
-
2021
- 2021-12-02 US US17/457,308 patent/US20220087976A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR102421013B1 (ko) | 2022-07-14 |
| CA3024284A1 (en) | 2017-11-23 |
| US11207295B2 (en) | 2021-12-28 |
| AU2017267160B2 (en) | 2022-11-10 |
| RU2018144784A (ru) | 2020-06-19 |
| JP2019516722A (ja) | 2019-06-20 |
| US20220087976A1 (en) | 2022-03-24 |
| DK3459542T3 (da) | 2021-09-13 |
| RU2751504C2 (ru) | 2021-07-14 |
| CN109310669B (zh) | 2022-02-22 |
| WO2017200317A1 (ko) | 2017-11-23 |
| BR112018073556A2 (pt) | 2019-03-19 |
| CN109310669A (zh) | 2019-02-05 |
| AU2017267160A1 (en) | 2018-12-13 |
| EP3459542A1 (en) | 2019-03-27 |
| JP6960415B2 (ja) | 2021-11-05 |
| US20190175555A1 (en) | 2019-06-13 |
| RU2018144784A3 (enExample) | 2020-08-11 |
| MX2018014081A (es) | 2019-09-02 |
| PT3459542T (pt) | 2021-08-24 |
| EP3459542B1 (en) | 2021-06-30 |
| CA3024284C (en) | 2024-01-23 |
| PL3459542T3 (pl) | 2021-12-27 |
| MX389613B (es) | 2025-03-20 |
| EP3459542A4 (en) | 2020-01-08 |
| KR20170131241A (ko) | 2017-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2743153T3 (es) | Métodos para tratar el síndrome de fibromialgia | |
| JP7071287B2 (ja) | 繊維筋痛又は繊維筋痛の関連する機能的症候群を予防又は治療するためのカルバメート化合物の使用 | |
| US20220087976A1 (en) | Use of carbamate compound for preventing or treating trigeminal neuralgia | |
| JP7578747B2 (ja) | 欠神発作又は欠神発作を示すてんかんの予防、軽減又は治療のためのカルバメート化合物の使用 | |
| US11571410B2 (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| US12070448B2 (en) | Use of carbamate compound for prevention, alleviation or treatment of status epilepticus | |
| ES3039979T3 (en) | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome | |
| ES2207544T3 (es) | Derivados de 2-aminotetralina para la terapia del glaucoma. | |
| BR112018073556B1 (pt) | Uso de um composto de carbamato | |
| KR20210062029A (ko) | 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도 | |
| RU2787771C2 (ru) | Применение карбаматного производного для предотвращения, облегчения или лечения малого эпилептического припадка или эпилепсии, проявляющей малый эпилептический припадок | |
| HK40003859A (en) | Use of carbamate compound for preventing or treating trigeminal neuralgia | |
| HK40003859B (en) | Use of carbamate compound for preventing or treating trigeminal neuralgia | |
| JO et al. | Use of carbamate compound for preventing or treating trigeminal neuralgia | |
| HK40005640A (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | |
| HK40005640B (en) | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia |